Lotte Biologics and Merck News and Resources

Lotte Biologics and Merck have entered a strategic partnership, formalised through a Letter of Intent (LOI) signed on June 14, 2024. The agreement focuses on biopharmaceutical manufacturing and process development. The signing ceremony featured key executives, including Richard Lee, CEO